Background: Subtle age-related cognitive decline may be associated with the capacity to remain engaged in mental, physical, and social activities. Informant reports of cognitive decline potentially provide additional information to psychometric tests on change in everyday cognitive function relevant to activity engagement. Objective: To investigate relations between decline in everyday cognitive function as assessed by informant report and activity engagement in community-dwelling older adults. Methods: A sample of cognitively normal older adults was drawn from the 2 latest waves of the PATH Through Life Study (n = 1,391; mean age 74.5 ± 1.5, 48.4% female). PATH is a 16-year longitudinal cohort study set in the Canberra/Queanbeyan district, Australia. Assessments were carried out at baseline, and at 3 subsequent time-points 4 years apart. At wave-4, the IQCODE, an informant measure of 4-year cognitive decline was provided by a spouse, family member, or friend of each participant. Activity engagement was assessed by the abbreviated RIASEC Mental Activity List, self-reported frequency and duration of physical activity (Whitehall Questionnaire) and the Lubben Social Network Scale that assessed interaction with family/friends. Participants provided demographic information, self-reported health status (SF-12), and responses to the Goldberg Depression Scale. The Symbol Digit Modalities Test (SDMT) and California Verbal Learning Test (CVLT) were used to measure objective 4-year cognitive change. Those with MMSE score of ≤27 were excluded. Results: IQCODE score predicted disengagement from mental activities over 4 years in cognitively healthy adults (β = -0.056, standard error [SE] = 0.019, p = 0.004). This association was robust to covariate control and change on the SDMT which was also significantly related to mental activity disengagement. In models adjusted for change scores on the SDMT and the CVLT, the IQCODE was associated with less physical (β = -0.692, SE = 0.24, p = 0.004) and social engagement (β -0.046, SE = 0.021, p = 0.032), but relationships were attenuated with the inclusion of covariates. Conclusion: Informant-reported cognitive decline in a non-clinical sample was linked to activities that support cognitive health. Associations were robust to adjustment for cognitive change scores. Utilising informant reports prior to the manifestation of clinically relevant decline may identify those who would benefit most from personalised activity interventions.

Keywords:
Informant reports, Cognitive decline, Lifestyle activities, Engagement
1.
Salthouse T: Consequences of age-related cognitive declines. Annu Rev Psychol 2012;63:201-226.
2.
Verhaeghen P, Martin M, Sędek G: Reconnecting cognition in the lab and cognition in real life: the role of compensatory social and motivational factors in explaining how cognition ages in the wild. Aging Neuropsychol Cogn 2012;19:1-12.
3.
Hess TM: Selective engagement of cognitive resources: motivational influences on older adults' cognitive functioning. Perspect Psychol Sci 2014;9:388-407.
4.
Carlson MC, Kuo JH, Chuang YF, Varma VR, Harris G, et al: Impact of the Baltimore Experience Corps Trial on cortical and hippocampal volumes. Alzheimers Dement 2015;11:1340-1348.
5.
Park DC, Lodi-Smith J, Drew L, Haber S, Hebrank A, et al: The impact of sustained engagement on cognitive function in older adults: the synapse project. Psychol Sci 2014;25:103-112.
6.
Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, et al: Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA. 2011;108:3017-3022.
7.
Aartsen MJ, Smits CHM, van Tilburg T, Knipscheer KCPM, Deeg DJH: Activity in older adults: cause or consequence of cognitive functioning? A longitudinal study on everyday activities and cognitive performance in older adults. J Gerontol B Psychol Sci Soc Sci 2002;57:P153-P162.
8.
Hultsch DF, Hertzog C, Small BJ, Dixon RA: Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging? Psychol Aging 1999;14:245-263.
9.
Mackinnon A, Christensen H, Hofer SM, Korten AE, Jorm AF: Use it and still lose it? The association between activity and cognitive performance established using latent growth techniques in a community sample. Aging Neuropsychol Cogn 2003;10:215-229.
10.
Ghisletta P, Bickel JF, Lovden M: Does activity engagement protect against cognitive decline in old age? Methodological and analytical considerations. J Gerontol B Psychol Sci Soc Sci 2006;61:P253-P261.
11.
Small BJ, Dixon RA, McArdle JJ, Grimm KJ: Do changes in lifestyle engagement moderate cognitive decline in normal aging? Evidence from the Victoria Longitudinal Study. Neuropsychology 2012;26:144-155.
12.
Bielak AAM, Gerstorf D, Anstey KJ, Luszcz MA: Longitudinal associations between activity and cognition vary by age, activity type, and cognitive domain. Psychol Aging 2014;29:863-872.
13.
Singh-Manoux A, Kivimaki M, Glymour MM, Elbaz A, Berr C, et al: Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 2012;344: d7622.
14.
Yam A, Gross A, Prindle J, Marsiske M: Ten-year longitudinal trajectories of older adults' basic and everyday cognitive abilities. Neuropsychology 2014;28:819-828.
15.
Allaire JC, Gamlado AA: Everyday cognition; in Pachana NA (ed): Encyclopedia of Geropsychology. Singapore, Springer, 2015, pp 1-7.
16.
Jorm AF, Jacomb PA: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989;19:1015-1022.
17.
Jorm AF, Broe GA, Creasey H, Sulway MR, Dent O, et al: Further data on the validity of the informant questionnaire on cognitive decline in the elderly (IQCODE). Int J Geriatr Psychiatry 1996;11:131-139.
18.
Jorm AF, Christensen H, Henderson AS, Jacomb PA, Korten AE, et al: Informant ratings of cognitive decline of elderly people: relationship to longitudinal change on cognitive tests. Age Ageing 1996;25:125-129.
19.
Quinn TJ, Fearon P, Noel-Storr AH, Young C, McShane R, et al: Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations. Cochrane Database Syst Rev 2014;4:CD010079.
20.
Harrison JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, et al: Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting. Cochrane Database Syst Rev 2015;3:CD010772.
21.
Anstey KJ, Christensen H, Butterworth P, Easteal S, Mackinnon A, et al: Cohort Profile: The PATH through life project. Int J Epidemiol 2012;41:951-960.
22.
O'Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, et al: Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol 2008;65:963-967.
23.
Kerby DS, Ragan KM: Activity interests and Holland's Riasec System in older adults. Int J Aging Hum Dev 2002;55:117-139.
24.
Bielak AA, Anstey KJ, Christensen H, Windsor TD: Activity engagement is related to level, but not change in cognitive ability across adulthood. Psychol Aging 2012;27:219-228.
25.
Stafford M, Hemingway H, Stansfeld SA, Brunner E, Marmot M: Behavioural and biological correlates of physical functioning in middle aged office workers: the UK Whitehall II Study. J Epidemiol Community Health 1998;52:353-358.
26.
Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, et al: Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist 2006;46:503-513.
27.
Ware J Jr, Kosinski M, Keller SD: A 12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
28.
Goldberg D, Bridges K, Duncan-Jones P, Grayson D: Detecting anxiety and depression in general medical settings. BMJ 1988;297:897-899.
29.
Kiely KM, Butterworth P, Watson N, Wooden M: The symbol digit modalities test: normative data from a large nationally representative sample of Australians. Arch Clin Neuropsychol 2014;29:767-775.
30.
Delis DC, Kramer JH, Kaplan E, Ober BA: California Verbal Learning Test: Adult Version. San Antonio, Psychological Corporation, Harcourt Brace & Company, 1987.
31.
Schafer JL, Graham JW: Missing data: our view of the state of the art. Psychol Methods 2002;7:147-177.
32.
Wang H-X, Xu W, Pei J-J: Leisure activities, cognition and dementia. Biochim Biophys Acta 2012;1822:482-491.
33.
Gow AJ, Corley J, Starr JM, Deary IJ: Reverse causation in activity-cognitive ability associations: the Lothian Birth Cohort 1936. Psychol Aging 2012;27:250-255.
34.
Farias ST, Mungas D, Reed B, Haan MN, Jagust WJ: Everyday functioning in relation to cognitive functioning and neuroimaging in community-dwelling Hispanic and non-Hispanic older adults. J Int Neuropsychol Soc 2004;10:342-354.
35.
Allan JL, McMinn D, Daly M: A bidirectional relationship between executive function and health behavior: evidence, implications, and future directions. Front Neurosci 2016;10:386.
36.
Spiro A, Brady CB: Opportunities and challenges for interdisciplinary research; in Hofer SM, Alwin DF (eds): Handbook of Cognitive Aging: Interdisciplinary Perspectives. Thousand Oaks, SAGE Publications, 2008, pp 260-282.
37.
Daly M, McMinn D, Allan JL: A bidirectional relationship between physical activity and executive function in older adults. Front Hum Neurosci 2014;8:1044.
38.
Wassink-Vossen S, Collard RM, Oude Voshaar RC, Comijs HC, de Vocht HM, et al: Physical (in)activity and depression in older people. J Affect Disord 2014;161:65-72.
39.
Rabin LA, Wang C, Katz MJ, Derby CA, Buschke H, et al: Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficulties. J Am Geriatr Soc 2012;60:1128-1134.
40.
Valech N, Mollica MA, Olives J, Tort A, Fortea J, et al: Informants' perception of subjective cognitive decline helps to discriminate preclinical Alzheimer's disease from normal aging. J Alzheimers Dis 2015;48(suppl 1):S87-S98.
41.
Jorm AF: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review. Int Psychogeriatr 2004;16:275-293.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.